Limit Quinolones Due to Aortic Aneurysm and Rupture Risks
February 2019
Rupture of aortic aneurysm is the latest quinolone risk...leading FDA to require added warnings on oral and injectable quinolone labels.
Aortic aneurysm and rupture are rare...and may occur in about one in every 11,000 patients overall each year. But they can be fatal.
That number can jump to one in about 300 high-risk patients. This includes the elderly...patients with a history of aneurysm, hypertension, vascular disease, or smoking...or those with some genetic conditions.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote